limited with poor recruitment and high attrition rates making interpretation of results challenging. Aims To analyse recruitment from a UK multisite study in 5 SPCUs which recruited above target and compare recruitment strategies with recommendations from the 'Social Marketing Mix Framework' (SMMF) and learn lessons for future research in SPCUs. Methods Recruitment data from the HIDDen (Hospice Inpatient DVT Detection) Study was analysed and compared with SMMF recommendations for improving recruitment to trials in palliative care. Results Over 17 months 1390 patients with cancer were screened for HIDDen study inclusion in five SPCUs (three in N. Ireland, one in England and one in Wales) 797 (57%) patients were ineligible. 206 (35% of those eligible) declined participation with 387 (65% of those eligible) recruited. When compared with the '6Ps' of SMMF the study protocol addressed 'Participants' with broad study eligibility criteria 'Product' by replicating clinical practice with no change to routine clinical care and no competing trials 'Price' through minimising patient and carer burden and easing the consent process 'Place' by being done in patients own room in the SPCU and using five sites 'Promoting' through role play and maintaining the research profile and 'Partners' by addressing gatekeeping and minimising input from clinical staff by having on-site research staff. Discussion Good recruitment to trials is possible in a SPCU setting and use of the '6Ps' of SMMF can help in trial design and recruitment. Background Patients receiving palliative care are vulnerable to patient safety incidents but little is known about the extent of harm caused or the origins of unsafe care in this population. Aim To quantify and qualitatively analyse serious incident reports in order to understand the causes and impact of unsafe care in a population receiving palliative care. Setting and participants Reports to a national database of 'serious incidents requiring investigation' involving patients receiving palliative care in the National Health Service (NHS) in England during the twelve year period April 2002 to March 2014.
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Introduction SEGT has been found to be a valuable manualised model of therapy for reducing emotional distress facilitating the person's management of the disease-related symptoms and improving quality of life in cancer populations (Butler et al. 2009; Classen et al. 2001; Lemieux et al. 2007) . The fundamental domains covered by this model include promoting emotional expression confronting existential issues and optimising social support (Classen et al. 2001; Spiegel Bloom and Yalom 1981) . Despite trials there are to our knowledge no systematic reviews that have sought to critic and pool evidence from all Randomised Controlled Trials (RCTs) on SEGT for people with advanced disease. 
